Govwatch

Introduced

In Committee

3

Passed One Chamber

4

Passed Both

5

Signed into Law

Sponsor

Diana DeGette

Democrat · CO · Representative

Votes with party: 98.0% (661 recorded votes)

Full profile: /officials/D000197

Source: Congress.gov · FEC

Cosponsors (24)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-11-18

Source: Congress.gov

Committee Activity

Currently in

House Committee on Energy and CommerceReferred To · 2025-11-18

Previously

Energy and Commerce CommitteeReferred To · 2025-11-18

Plain-English Summary

Fracturing Responsibility and Awareness of Chemicals Act of 2025 This bill modifies drinking water requirements concerning hydraulic fracturing (fracking) operations, including by giving the Environmental Protection Agency (EPA) the authority to protect groundwater sources (e.g., wells) from certain pollution risks posed by fracking operations. The bill also establishes requirements for disclosing the chemicals intended for use in fracking operations as well as the chemicals actually used in the operations. If the proprietary chemical formulas of chemicals used in fracking operations are necessary for treatment in medical emergencies, then the operations must disclose the formulas or the specific chemical identities of trade secret chemicals to the state, the EPA, or the treating physicians or nurses upon request, regardless of whether written statements of need or confidentiality agreements have been provided.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Environmental Protection

Full bill text is not yet cached locally.

Open text view Read on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

HR10227INSULIN Act of 2026
Referred to Committee · 2026-09-02
HR3491DeOndra Dixon INCLUDE Project Act of 2025
Passed House · 2026-07-21
HR9392Medicare Advantage Cost Transparency Act
Referred to Committee · 2026-06-25
HRES1285Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Referred to Committee · 2026-05-14